207 related articles for article (PubMed ID: 28498921)
1. A meta-analysis of the use of rifaximin to prevent travellers' diarrhoea.
Ng QX; Ho CYX; Shin D; Venkatanarayanan N; Chan HW
J Travel Med; 2017 Sep; 24(5):. PubMed ID: 28498921
[TBL] [Abstract][Full Text] [Related]
2. Safety and tolerability of the antibacterial rifaximin in the treatment of travellers' diarrhoea.
Ericsson CD
Drug Saf; 2006; 29(3):201-7. PubMed ID: 16524320
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of rifaximin in prevention of diarrhoea in individuals travelling to south and southeast Asia: a randomised, double-blind, placebo-controlled, phase 3 trial.
Zanger P; Nurjadi D; Gabor J; Gaile M; Kremsner PG
Lancet Infect Dis; 2013 Nov; 13(11):946-54. PubMed ID: 24012319
[TBL] [Abstract][Full Text] [Related]
4. Travellers' diarrhoea: contemporary approaches to therapy and prevention.
DuPont HL
Drugs; 2006; 66(3):303-14. PubMed ID: 16526819
[TBL] [Abstract][Full Text] [Related]
5. Review article: rifaximin, a minimally absorbed oral antibacterial, for the treatment of travellers' diarrhoea.
Layer P; Andresen V
Aliment Pharmacol Ther; 2010 Jun; 31(11):1155-64. PubMed ID: 20331580
[TBL] [Abstract][Full Text] [Related]
6. Systematic review: prevention of travellers' diarrhoea.
DuPont HL
Aliment Pharmacol Ther; 2008 May; 27(9):741-51. PubMed ID: 18284650
[TBL] [Abstract][Full Text] [Related]
7. Travellers' diarrhoea.
Ericsson CD
Int J Antimicrob Agents; 2003 Feb; 21(2):116-24. PubMed ID: 12615374
[TBL] [Abstract][Full Text] [Related]
8. ▾Rifaximin for the treatment of travellers' diarrhoea?
Drug Ther Bull; 2013 Jan; 51(1):10-2. PubMed ID: 23303506
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of rifaximin against clinical isolates of Escherichia coli and other enteropathogenic bacteria isolated from travellers returning to the UK.
Hopkins KL; Mushtaq S; Richardson JF; Doumith M; de Pinna E; Cheasty T; Wain J; Livermore DM; Woodford N
Int J Antimicrob Agents; 2014 May; 43(5):431-7. PubMed ID: 24661532
[TBL] [Abstract][Full Text] [Related]
10. Systematic review: the epidemiology and clinical features of travellers' diarrhoea.
DuPont HL
Aliment Pharmacol Ther; 2009 Aug; 30(3):187-96. PubMed ID: 19392866
[TBL] [Abstract][Full Text] [Related]
11. Use of antimicrobial agents for treatment and prevention of travellers' diarrhoea in the face of enhanced risk of transient fecal carriage of multi-drug resistant enterobacteriaceae: setting the stage for consensus recommendations.
DuPont HL; Steffen R
J Travel Med; 2017 Apr; 24(suppl_1):S57-S62. PubMed ID: 28881862
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala.
Behrens RH; Cramer JP; Jelinek T; Shaw H; von Sonnenburg F; Wilbraham D; Weinke T; Bell DJ; Asturias E; Pauwells HL; Maxwell R; Paredes-Paredes M; Glenn GM; Dewasthaly S; Stablein DM; Jiang ZD; DuPont HL
Lancet Infect Dis; 2014 Mar; 14(3):197-204. PubMed ID: 24291168
[TBL] [Abstract][Full Text] [Related]
13. Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoea.
Ahmed T; Bhuiyan TR; Zaman K; Sinclair D; Qadri F
Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD009029. PubMed ID: 23828581
[TBL] [Abstract][Full Text] [Related]
14. Analysis of Escherichia coli isolates from subjects with travellers' diarrhoea using DNA probes and serotyping.
Rademaker CM; Krul MR; Jansen WH; Vos NM; Hoepelman IM; Rozenberg-Arska M; Verhoef J
Eur J Clin Microbiol Infect Dis; 1991 Aug; 10(8):625-9. PubMed ID: 1748115
[TBL] [Abstract][Full Text] [Related]
15. Use of antimicrobial agents for treatment and prevention of travellers' diarrhoea in the face of enhanced risk of transient fecal carriage of multi-drug resistant enterobacteriaceae: setting the stage for consensus recommendations.
DuPont HL; Steffen R
J Travel Med; 2016 Jun; 23(6):. PubMed ID: 27503854
[TBL] [Abstract][Full Text] [Related]
16. Rifaximin: a review of its use in the management of traveller's diarrhoea.
Robins GW; Wellington K
Drugs; 2005; 65(12):1697-713. PubMed ID: 16060706
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of rifaximin and fluoroquinolones in preventing travelers' diarrhea (TD): a systematic review and meta-analysis.
Alajbegovic S; Sanders JW; Atherly DE; Riddle MS
Syst Rev; 2012 Aug; 1():39. PubMed ID: 22929178
[TBL] [Abstract][Full Text] [Related]
18. Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial.
Frech SA; Dupont HL; Bourgeois AL; McKenzie R; Belkind-Gerson J; Figueroa JF; Okhuysen PC; Guerrero NH; Martinez-Sandoval FG; Meléndez-Romero JH; Jiang ZD; Asturias EJ; Halpern J; Torres OR; Hoffman AS; Villar CP; Kassem RN; Flyer DC; Andersen BH; Kazempour K; Breisch SA; Glenn GM
Lancet; 2008 Jun; 371(9629):2019-25. PubMed ID: 18554712
[TBL] [Abstract][Full Text] [Related]
19. [Antibiotic treatment of travellers' diarrhea].
Klinge L; de Muckadell OB
Ugeskr Laeger; 2001 Aug; 163(34):4571-3. PubMed ID: 11530563
[TBL] [Abstract][Full Text] [Related]
20. Ecological effects of short-term ciprofloxacin treatment of travellers' diarrhoea.
Wiström J; Gentry LO; Palmgren AC; Price M; Nord CE; Ljungh A; Norrby SR
J Antimicrob Chemother; 1992 Nov; 30(5):693-706. PubMed ID: 1493985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
